 "Guidelines on Covaxin for under 18 don't mention EUL by WHO: Govt")
The Union Health Ministry on Friday termed as "highly ill-informed" and "misleading" media reports suggesting that approval for the Covaxin vaccine in the 15-18 age group has been given despite the WHO not having accorded Emergency Use Listing (EUL) to its use in this age bracket.
The guidelines issued by the Union Ministry of Health at no place mention about EUL by WHO, it said.
Such reports are highly ill-informed, misleading and far from the truth, it said in a statement.
The guidelines issued by the Ministry on December 27, 2021, under the heading New beneficiaries aged 15-18 years state that "For such beneficiaries, option for vaccination would only be available for Covaxin as this is the only vaccine with EUL for the age-group 15-18", it said in a statement.
The EUL by CDSCO, the national regulator, for Covaxin vaccine for age group 12-18 age group was accorded on December 24, 2021.
Subsequently, the guidelines for vaccination of 15-18 yr age group of young adults and precaution dose for other identified categories was issued by it on December 27, the ministry added.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app